【药物名称】
化学结构式(Chemical Structure):
参考文献No.56772
标题:Neuroprotective substd. piperidine cpds. with activity as NMDA NR2B subtype selective antagonists
作者:Wyler, R.; Buettelmann, B.; Alanine, A.; Pinard, E.; Jaeschke, G.; Neidhart, M.-P. (Hoffmann-La Roche, Inc.)
来源:US 6432985; WO 0181309
合成路线图解说明:

Acylation of 4-benzyl-4-hydroxypiperidine (I) by means of benzyl chloroformate provides carbamate (II). Subsequent dehydration of the tertiary alcohol group of (II) employing SOCl2 and pyridine leads to the tetrahydropyridine (III). Oxidation of tetrahydropyridine (III) with m-chloroperbenzoic acid gives epoxide (IV) which, upon acidic hydrolysis, is converted to the trans-diol (V). Resolution of the racemic diol (V) is performed via esterification with (S)-N-trifluoroacetylproline chloride (VI), followed by chromatographic separation of the resultant diastereomeric esters. The desired isomer (VII) is then hydrolyzed under basic conditions to yield the (R,R)-diol (VIII). Removal of the N-carbobenzoxy group of (VIII) by hydrogenolysis leads to (R,R)-4-benzyl-3,4-dihydroxypiperidine (IX), which is alkylated by the alkyl chloride (X) to produce (XI). Finally, hydrogenolysis of the benzyl ether group of (XI) furnishes the title compound.

Drug Information Express,Drug R&D,Chemical Database,Patent Search.
Copyright © 2006-2024 Drug Future. All rights reserved.Contact Us